Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed May 20, 2014 · 10-Q · 50 days after period end · 0001424884-14-000060
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Net Income | -$29.71M | -$441.43K | -$598.57K | -$1.27M |
| EPS Diluted | -$3.89 | -$0.55 | -$0.01 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 20, 2014 · 50 d after period end
